“…During ischemia reperfusion (I/R), tissues are subjected to the destructive proinflammatory cytokines and reactive oxygen species released by inflammatory cells, leading to inflammatory injury and cell apoptosis [2,3]. II/R also affects the secondary organs, including liver [4], heart [5], kidney [6], and lung [7], and even causes multiple organ failure (MOF), a common cause of mortality. Therefore, seeking anti-oxidative, anti-inflammatory, and antiapoptotic agents to attenuate multiple organ injury induced by II/R is urgently required.…”